NCT00962377View on ClinicalTrials.gov

A Comparison of AlloMap Molecular Testing and Traditional Biopsy-based Surveillance for Heart Transplant Rejection Early Post-transplantation

NAUnknownINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Graft RejectionHeart Diseases
Interventions
PROCEDURE

Endomyocardial biopsy

Right ventricular endomyocardial biopsy in monitoring of asymptomatic heart transplant patients for acute cellular rejection

PROCEDURE

AlloMap Molecular Testing

Gene expression profiling in the monitoring of asymptomatic heart transplant patients for acute cellular rejection.

Trial Locations (1)

90211

Cedars-Sinai Medical Center, Beverly Hills

Sponsors

Lead Sponsor

XDx
All Listed Sponsors
lead

XDx

INDUSTRY

NCT00962377 - A Comparison of AlloMap Molecular Testing and Traditional Biopsy-based Surveillance for Heart Transplant Rejection Early Post-transplantation | Biotech Hunter | Biotech Hunter